In individuals with type 2 diabetes, close monitoring of blood sugar levels is crucial
EP2348044A1 - Ion exchange chromatography of GLP-1, analogs and derivatives thereof - Google Patents Ion exchange chromatography of GLP-1, analogs and derivatives thereof Download PDF Info Publication number EP2348044A1 EP2348044A1 EP10178161A EP10178161A EP2348044A1 EP 2348044 A1 EP2348044 A1 EP 2348044A1 EP 10178161 A EP10178161 A EP 10178161A EP 10178161 A EP10178161 A EP 10178161A EP 2348044 A1 EP2348044 A1 EP 2348044A1 Authority EP European Patent Office Prior art keywords peptide glp gradient buffers linear Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
Formulation Patents : These cover the specific buffers, stabilizers, and surfactants used to keep the peptide stable in a syringe or tablet
Meanwhile, exogenous neutralizing antibodies may help those not responsive to the SARS-Cov-2 vaccines
Morphologic features of mucosal injury were based on different grades of epithelial lifting, villi denudation, and necrosis
Front Endocrinol (Lausanne) 12:645566 Zhang Y et al (2022) Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
